Albemarle launches $1.3-billion stock offering, expects sequential sales increase
22:45 PM | February 2, 2021 | Vincent Valk
Albemarle will also use the proceeds to pursue "opportunities in China," and for short-term debt repayment and general corporate purposes.
This information is only available to subscribers
chemweek.com is the one stop platform for chemical news, data and analysis across all industry sectors and geographies.